Publication | Open Access

Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study

UrologyOncologyPrednisone Versus PlaceboAbiraterone AcetateMedicinePharmacotherapyCastration-resistant Prostate CancerCancer TreatmentProstatic DiseasePharmacology